Journal Logo

Articles by Suguru Yamada

Transcriptomic Profiling Identifies an Exosomal microRNA Signature for Predicting Recurrence Following Surgery in Patients with Pancreatic Ductal Adenocarcinoma

Nishiwada, Satoshi; Cui, Ya; Sho, Masayuki; More

Annals of Surgery. Post Acceptance: June 16, 2021

Results of a Phase II Study on the Use of Neoadjuvant Chemotherapy (FOLFIRINOX or GEM/nab-PTX) for Borderline-resectable Pancreatic Cancer (NUPAT-01)

Yamaguchi, Junpei; Yokoyama, Yukihiro; Fujii, Tsutomu; More

Annals of Surgery. 275(6):1043-1049, June 2022.

Significance of SYT8 For the Detection, Prediction, and Treatment of Peritoneal Metastasis From Gastric Cancer

Kanda, Mitsuro; Shimizu, Dai; Tanaka, Haruyoshi; More

Annals of Surgery. 267(3):495-503, March 2018.

Multicenter Phase II Study of Intravenous and Intraperitoneal Paclitaxel With S-1 for Pancreatic Ductal Adenocarcinoma Patients With Peritoneal Metastasis

Satoi, Sohei; Fujii, Tsutomu; Yanagimoto, Hiroaki; More

Annals of Surgery. 265(2):397-401, February 2017.

Correlation Between Radiographic Classification and Pathological Grade of Portal Vein Wall Invasion in Pancreatic Head Cancer

Nakao, Akimasa; Kanzaki, Akiyuki; Fujii, Tsutomu; More

Annals of Surgery. 255(1):103-108, January 2012.

Invasion of the Splenic Artery Is a Crucial Prognostic Factor in Carcinoma of the Body and Tail of the Pancreas

Kanda, Mitsuro; Fujii, Tsutomu; Sahin, Tevfik T.; More

Annals of Surgery. 251(3):483-487, March 2010.

Clinical Implications of Peritoneal Cytology in Potentially Resectable Pancreatic Cancer: Positive Peritoneal Cytology May Not Confer an Adverse Prognosis

Yamada, Suguru; Takeda, Shin; Fujii, Tsutomu; More

Annals of Surgery. 246(2):254-258, August 2007.